Market Overview:
The global blood screening market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of blood-borne diseases, growing demand for safe and quality blood products, and technological advancements in the field of blood screening. The global blood screening market is segmented on the basis of type, application, and region. On the basis of type, it is divided into reagent and instrument. Reagents are further classified into antibodies, enzymes, nucleic acids probes (NAbs), proteins & peptides etc., while instruments are categorized as flow cytometers (FCMs), spectrophotometers etc. By application, it is segmented into two segments: Blood bank and hospital laboratory settings.
Product Definition:
A blood screening is a laboratory test performed on a sample of blood. The purpose of the test is to detect the presence of certain substances in the blood that may indicate an illness or disease. Blood screenings are important because they can help identify health problems early, when treatment may be more effective.
Reagent:
Reagents are chemicals that undergo a change when exposed to specific conditions such as heat, pH or enzymes. The most common reagents used in laboratories are stains, fixatives and solubilizers. Reagent is also used for research purposes by scientists across the globe.
Reagents have wide applications in medical diagnostics and therapeutics fields due to their specificity and sensitivity towards biological systems.
Instrument:
Instrument is any device or kit used for testing the blood. It can be a simple device or highly sophisticated equipment which helps in analyzing the blood for various parameters such as hemoglobin, hematocrit, and count of white blood cells (WBC).
Application Insights:
The blood bank segment dominated the global market in terms of revenue in 2017. The increasing number of transfusion cases and rising awareness about Type O negative blood are some of the factors responsible for its dominance over the forecast period.
Hospital based testing is expected to witness significant growth owing to an increase in demand for point-of-care tests that can identify infectious diseases rapidly, at a low cost and with high accuracy. Moreover, these tests are also able to detect drug resistance which further boosts their demand across hospitals globally. Increasing investments by governments as well as private institutions to develop/upgrade diagnostic tools & technologies that can help prevent spread of infectious diseases will drive this application segment over the forecast period.
Regional Analysis:
North America dominated the global blood screening market in 2017. The presence of well-established healthcare infrastructure, high adoption rate of advanced technologies, and favorable reimbursement policies are some factors responsible for its large share. In addition, increasing demand for organ transplants is also expected to drive the regional market growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income and improving healthcare infrastructure in emerging countries such as China and India. Furthermore, an increase in road accidents leading to a rise in chronic diseases such as cancer and heart diseases is also driving demand for blood tests from this region. For instance, according to NCBI; around 1 million people die due to cancer every year in China alone which constitutes about 3% of total deaths annually (NCBI).
Growth Factors:
- Increasing incidence of lifestyle diseases such as diabetes and hypertension is expected to drive the demand for blood screening services.
- Growing awareness about the benefits of early diagnosis and treatment is likely to boost the demand for blood screening services over the forecast period.
- Technological advancements in blood screening equipment are expected to result in increased adoption of these devices, thereby driving market growth.
- Rising number of cancer patients is anticipated to fuel the demand for blood profiling services over the next few years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Blood Screening Market Research Report
By Type
Reagent, Instrument
By Application
Blood Bank, Hospital
By Companies
Abbott Laboratories, Alere Inc., Apex Biotechnology Corp., Beckman Coulter (A Subsidiary of Danaher Corporation), Becton, Dickinson and Company, Biomrieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche, Grifols, Hem
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
239
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Blood Screening Market Report Segments:
The global Blood Screening market is segmented on the basis of:
Types
Reagent, Instrument
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Blood Bank, Hospital
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Alere Inc.
- Apex Biotechnology Corp.
- Beckman Coulter (A Subsidiary of Danaher Corporation)
- Becton, Dickinson and Company
- Biomrieux
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche
- Grifols
- Hem
Highlights of The Blood Screening Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Reagent
- Instrument
- By Application:
- Blood Bank
- Hospital
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Blood Screening Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Blood screening is a process of checking for diseases by looking at the blood.
Some of the major players in the blood screening market are Abbott Laboratories, Alere Inc., Apex Biotechnology Corp., Beckman Coulter (A Subsidiary of Danaher Corporation), Becton, Dickinson and Company, Biomrieux, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche, Grifols, Hem.
The blood screening market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Blood Screening Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Blood Screening Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Blood Screening Market - Supply Chain
4.5. Global Blood Screening Market Forecast
4.5.1. Blood Screening Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Blood Screening Market Size (000 Units) and Y-o-Y Growth
4.5.3. Blood Screening Market Absolute $ Opportunity
5. Global Blood Screening Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Blood Screening Market Size and Volume Forecast by Type
5.3.1. Reagent
5.3.2. Instrument
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Blood Screening Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Blood Screening Market Size and Volume Forecast by Application
6.3.1. Blood Bank
6.3.2. Hospital
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Blood Screening Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Blood Screening Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Blood Screening Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Blood Screening Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Blood Screening Demand Share Forecast, 2019-2029
9. North America Blood Screening Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Blood Screening Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Blood Screening Market Size and Volume Forecast by Application
9.4.1. Blood Bank
9.4.2. Hospital
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Blood Screening Market Size and Volume Forecast by Type
9.7.1. Reagent
9.7.2. Instrument
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Blood Screening Demand Share Forecast, 2019-2029
10. Latin America Blood Screening Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Blood Screening Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Blood Screening Market Size and Volume Forecast by Application
10.4.1. Blood Bank
10.4.2. Hospital
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Blood Screening Market Size and Volume Forecast by Type
10.7.1. Reagent
10.7.2. Instrument
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Blood Screening Demand Share Forecast, 2019-2029
11. Europe Blood Screening Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Blood Screening Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Blood Screening Market Size and Volume Forecast by Application
11.4.1. Blood Bank
11.4.2. Hospital
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Blood Screening Market Size and Volume Forecast by Type
11.7.1. Reagent
11.7.2. Instrument
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Blood Screening Demand Share, 2019-2029
12. Asia Pacific Blood Screening Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Blood Screening Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Blood Screening Market Size and Volume Forecast by Application
12.4.1. Blood Bank
12.4.2. Hospital
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Blood Screening Market Size and Volume Forecast by Type
12.7.1. Reagent
12.7.2. Instrument
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Blood Screening Demand Share, 2019-2029
13. Middle East & Africa Blood Screening Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Blood Screening Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Blood Screening Market Size and Volume Forecast by Application
13.4.1. Blood Bank
13.4.2. Hospital
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Blood Screening Market Size and Volume Forecast by Type
13.7.1. Reagent
13.7.2. Instrument
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Blood Screening Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Blood Screening Market: Market Share Analysis
14.2. Blood Screening Distributors and Customers
14.3. Blood Screening Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Alere Inc.
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Apex Biotechnology Corp.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Beckman Coulter (A Subsidiary of Danaher Corporation)
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Becton, Dickinson and Company
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Biomrieux
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Bio-Rad Laboratories, Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. F. Hoffmann-La Roche
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Grifols
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Hem
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
